Abstract

Many growth factors and G protein-coupled receptors activate mitogen-activated protein (MAP) kinase pathways. The MAP kinase pathways are involved in the regulation of the ubiquitous process of apoptosis or programmed cell death. Two related MAP kinase kinase kinases, apoptosis-signal regulating kinase 1 (ASK1) and MAP kinase kinase kinase 1 (MEKK1), stimulate c-Jun kinase (JNK) activity and induce apoptosis. Transient transfection of dominant negative and constitutively active components of the JNK pathway in COS-7 cells showed that two G protein subunits, Galpha12 and Galpha13, stimulated the JNK pathway in a ASK1- and MEKK1-dependent manner. Moreover, the mutationally activated Galpha12 and Galpha13 stimulated the kinase activity of ASK1. Both Galpha12 and Galpha13 employ small GTPases, Cdc42 and Rac1, to transduce signal to MEKK1 and, subsequently, to JNK. However, activation of JNK by Cdc42 and Rac1 did not require ASK1. Additionally, ASK1 and MEKK1 are involved in the apoptosis induced by Galpha12 and Galpha13. We conclude that Galpha12 and Galpha13 can induce apoptosis using two separate MAP kinase pathways; one is initiated by ASK1, and the other is initiated by MEKK1. Furthermore, Bcl-2 can block apoptosis induced by Galpha12 and Galpha13. This death-sparing function was associated with increased Bcl-2 phosphorylation, suggesting that phosphorylation of Bcl-2 may be a critical mechanism protecting cells from Galpha12- and Galpha13-induced apoptosis.

Highlights

  • Mitogen-activated protein (MAP)1 [1] kinases serve as a point of convergence for growth signals, including those generated from G protein-coupled receptors [1]

  • We found that both activation of Jun kinase (JNK) and apoptosis induced by G␣12 and G␣13 are mediated by two MAPK kinase (MAPKK) kinases, MAP kinase kinase kinase 1 (MEKK1) and apoptosis signal-regulating kinase 1 (ASK1)

  • In addition to MEKK1, other members of the MAP kinase family can mediate the regulation of JNK activity by G␣12 and G␣13, we used expression vectors encoding wild type and dominant negative ASK1

Read more

Summary

EXPERIMENTAL PROCEDURES

Materials—Protein A-agarose was obtained from Life Technologies, Inc. Antibodies to Bcl-2, G␣12, G␣13, MEKK1, and 9E10 antibody to c-Myc epitope were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). [␥-32P]ATP and [3H]adenine were obtained from NEN Life Science Products. Materials—Protein A-agarose was obtained from Life Technologies, Inc. Antibodies to Bcl-2, G␣12, G␣13, MEKK1, and 9E10 antibody to c-Myc epitope were obtained from Santa Cruz Biotechnology, Inc. [␥-32P]ATP and [3H]adenine were obtained from NEN Life Science Products. Polyclonal ␤-galactosidase antibody and rabbit rhodamine-conjugated IgG were purchased from Cappel and Pierce, respectively. The Apoptag Plus kit was purchased from Oncor. The production of ASK1 antibody (DAV) was described previously [22]

Heterotrimeric G Proteins and Apoptosis
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call